Identifying the cellular targets of CDKL5 is crucial because the CDD‐associated mutations strongly reduce kinase activity (Munoz et al, 2018), suggesting that the reduced phosphorylation of CDKL5 target proteins causes brain dysfunction and disease. This evidence concerns the gene CDKL5 and craniodiaphyseal dysplasia.